Skip to content

BioLineRx Ltd.

BLRX

CIK 0001498403

← back to feed
Revenue (TTM)
$1.18M
−95.9% YoY FY Mar 2026
Net Income (TTM)
−$29.44M
+78.0% YoY FY Mar 2026
EPS Diluted (TTM)
−$0.03
+100.0% YoY FY Mar 2026
Gross Margin
80.5%
FY Mar 2026
Operating Margin
-2,168.9%
FY Mar 2026
Net Margin
-2,495.3%
FY Mar 2026
Free Cash Flow (TTM)
—
FY Mar 2026
Cash
$3.25M
FY Mar 2026
Total Debt
—
FY Mar 2026
Shares Outstanding
2.61B sh
FY Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings